| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M508951200 |
| P698 | PubMed publication ID | 16251182 |
| P50 | author | Li Huang | Q39375954 |
| P2093 | author name string | Jing Zhou | |
| Christopher Aiken | |||
| David L Hachey | |||
| Chin Ho Chen | |||
| P2860 | cites work | The sequence of the CA-SP1 junction accounts for the differential sensitivity of HIV-1 and SIV to the small molecule maturation inhibitor 3-O-{3',3'-dimethylsuccinyl}-betulinic acid | Q24793247 |
| Entropic switch regulates myristate exposure in the HIV-1 matrix protein | Q27642873 | ||
| Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design | Q27730329 | ||
| High-efficiency transformation of mammalian cells by plasmid DNA | Q27860469 | ||
| AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly | Q28239650 | ||
| HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator | Q28307391 | ||
| Anti-human immunodeficiency virus activity of YK-FH312 (a betulinic acid derivative), a novel compound blocking viral maturation | Q28360742 | ||
| The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating | Q30196243 | ||
| The stoichiometry of Gag protein in HIV-1. | Q34328141 | ||
| Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments | Q34618267 | ||
| Betulinic acid derivatives as HIV-1 antivirals | Q36009015 | ||
| Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation | Q36944553 | ||
| PA-457: A potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing | Q37089562 | ||
| Evidence for a stable interaction of gp41 with Pr55(Gag) in immature human immunodeficiency virus type 1 particles | Q39593215 | ||
| Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail | Q40579232 | ||
| Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives | Q41066416 | ||
| Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells | Q42073571 | ||
| Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids | Q42285617 | ||
| Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents | Q42555749 | ||
| p24 antigen capture assay for quantification of human immunodeficiency virus using readily available inexpensive reagents | Q45761377 | ||
| P433 | issue | 51 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 42149-42155 | |
| P577 | publication date | 2005-10-25 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Inhibition of HIV-1 maturation via drug association with the viral Gag protein in immature HIV-1 particles | |
| P478 | volume | 280 |
| Q42424208 | 3-O-(3',3'-dimethysuccinyl) betulinic acid inhibits maturation of the human immunodeficiency virus type 1 Gag precursor assembled in vitro |
| Q28294677 | 3D Visualization of HIV Virions by Cryoelectron Tomography |
| Q34771244 | A sensitive assay using a native protein substrate for screening HIV-1 maturation inhibitors targeting the protease cleavage site between the matrix and capsid |
| Q42546287 | A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle |
| Q37336728 | A two-pronged structural analysis of retroviral maturation indicates that core formation proceeds by a disassembly-reassembly pathway rather than a displacive transition. |
| Q27324263 | Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors |
| Q45324180 | Alpha-helicoidal HEAT-like Repeat Proteins (αRep) Selected as Interactors of HIV-1 Nucleocapsid Negatively Interfere with Viral Genome Packaging and Virus Maturation |
| Q34552402 | Analysis of the N-terminal region of the murine leukemia virus nucleocapsid protein |
| Q38106149 | Bioengineering of plant (tri)terpenoids: from metabolic engineering of plants to synthetic biology in vivo and in vitro |
| Q45173552 | Determinants of activity of the HIV-1 maturation inhibitor PA-457. |
| Q30479297 | Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells |
| Q37287731 | Fullerene Derivatives Strongly Inhibit HIV-1 Replication by Affecting Virus Maturation without Impairing Protease Activity |
| Q24614498 | HIV type 1 Gag as a target for antiviral therapy |
| Q38539565 | HIV-1 assembly, release and maturation. |
| Q34529834 | HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice |
| Q36857103 | Human immunodeficiency virus type 1 assembly, release, and maturation. |
| Q30478394 | Human immunodeficiency virus type 1 resistance to the small molecule maturation inhibitor 3-O-(3',3'-dimethylsuccinyl)-betulinic acid is conferred by a variety of single amino acid substitutions at the CA-SP1 cleavage site in Gag |
| Q35992805 | Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage. |
| Q37192174 | Impact of human immunodeficiency virus type 1 resistance to protease inhibitors on evolution of resistance to the maturation inhibitor bevirimat (PA-457) |
| Q35107346 | Impaired infectivity of ritonavir-resistant HIV is rescued by heat shock protein 90AB1. |
| Q35184863 | In vitro analysis of human immunodeficiency virus particle dissociation: gag proteolytic processing influences dissociation kinetics |
| Q30832180 | In vitro protease cleavage and computer simulations reveal the HIV-1 capsid maturation pathway |
| Q35139703 | In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat). |
| Q38716274 | Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein |
| Q28554482 | Mechanistic Studies and Modeling Reveal the Origin of Differential Inhibition of Gag Polymorphic Viruses by HIV-1 Maturation Inhibitors |
| Q37967727 | Morphogenesis of the Infectious HIV-1 Virion |
| Q39763774 | Mutations in the spacer peptide and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding |
| Q37901613 | New approaches for antiviral targeting of HIV assembly |
| Q36691642 | New betulinic acid derivatives for bevirimat-resistant human immunodeficiency virus type-1. |
| Q43100320 | New triterpenoids from Arisaema jacquemontii |
| Q33624690 | Novel approaches to inhibiting HIV-1 replication. |
| Q26771739 | Pharmacological intervention of HIV-1 maturation |
| Q40750425 | Phenotypic susceptibility to bevirimat in isolates from HIV-1-infected patients without prior exposure to bevirimat |
| Q33864444 | Polymorphisms in Gag spacer peptide 1 confer varying levels of resistance to the HIV- 1 maturation inhibitor bevirimat |
| Q21092230 | Potent activity of the HIV-1 maturation inhibitor bevirimat in SCID-hu Thy/Liv mice |
| Q41844750 | Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process |
| Q36967857 | Recent progress in antiretrovirals--lessons from resistance |
| Q90646261 | Resistance to Second-Generation HIV-1 Maturation Inhibitors |
| Q25256613 | Review of "the Twelfth West Coast Retrovirus Meeting" and "the Twenty-third Annual Symposium on Nonhuman Primate Models for AIDS". |
| Q24812436 | Review of the twelfth West Coast Retrovirus Meeting |
| Q28485054 | Structural and functional insights into the HIV-1 maturation inhibitor binding pocket |
| Q28828191 | Structure-Activity Relationships of the Human Immunodeficiency Virus Type 1 Maturation Inhibitor PF-46396 |
| Q37928913 | Targeting human immunodeficiency virus type 1 assembly, maturation and budding. |
| Q27009643 | The choreography of HIV-1 proteolytic processing and virion assembly |
| Q30440445 | The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain |
| Q21245046 | The prototype HIV-1 maturation inhibitor, bevirimat, binds to the CA-SP1 cleavage site in immature Gag particles |
| Q30437103 | The structural biology of HIV assembly |
| Q39630669 | Triterpene derivatives that inhibit human immunodeficiency virus type 1 replication |
| Q24642446 | Virus maturation as a new HIV-1 therapeutic target |
Search more.